Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Chongqing Zhifei Biological Products Co Ltd
Cash from Operating Activities
Chongqing Zhifei Biological Products Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Operating Activities
¥3.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
106%
|
CAGR 10-Years
47%
|
|
Beigene Ltd
HKEX:6160
|
Cash from Operating Activities
-¥7.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Operating Activities
-¥1.7B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Operating Activities
¥1.5B
|
CAGR 3-Years
49%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Operating Activities
¥2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
55%
|
CAGR 10-Years
34%
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Operating Activities
¥1.2B
|
CAGR 3-Years
57%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Chongqing Zhifei Biological Products Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
3.6B
CNY
Based on the financial report for Sep 30, 2023, Chongqing Zhifei Biological Products Co Ltd's Cash from Operating Activities amounts to 3.6B CNY.
What is Chongqing Zhifei Biological Products Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
47%
Over the last year, the Cash from Operating Activities growth was 205%. The average annual Cash from Operating Activities growth rates for Chongqing Zhifei Biological Products Co Ltd have been 3% over the past three years , 106% over the past five years , and 47% over the past ten years .